ARTICLE | Company News
Allergan, Allergan Specialty deal
April 23, 2001 7:00 AM UTC
Eye care and specialty pharma company AGN, which spun out ASTI in 1997, exercised its option to reacquire all of ASTI's 3.3 million shares for $21.70 per share, or $71 million in cash. The purchase is...